PMEF
DNA icon

Point72 Middle East FZE’s Ginkgo Bioworks DNA Stock Holding History

Point72 Middle East FZE’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,082
Closed -$217K – 1668
2023
Q1 		$217K Buy
+4,082
New +$259K 0.01% 922

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

Point72 Middle East FZE's DNA Position: Q2 2023 in Review

Point72 Middle East FZE sold out of Ginkgo Bioworks (DNA) in Q2 2023, closing a stake of 4,082 shares — an estimated $217K sold.

Point72 Middle East FZE first reported a position in DNA in Q1 2023 and held it in 1 quarter. The position peaked at $217K in Q1 2023. 315 funds tracked by Wall St. Rank hold DNA as of Q2 2023.

  • Point72 Middle East FZE reported no remaining Ginkgo Bioworks position as of Q2 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 4,082 Ginkgo Bioworks shares in Q2 2023, an estimated $217K.
  • Point72 Middle East FZE first reported a position in Ginkgo Bioworks in Q1 2023 and held it in 1 quarter.
  • Point72 Middle East FZE's Ginkgo Bioworks position peaked at $217K in Q1 2023.
  • 315 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2023.

Based on Point72 Middle East FZE's 13F filing for Q2 2023, filed 14 Aug 2023.